RESEARCH-USE BIOSIMILAR ANTIBODY
Aducanumab
Monoclonal antibody · IgG1
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows blood-brain-barrier penetration, and can be used for Alzheimer's disease (AD) research.
TARGETAPP
YMonoclonal antibody
CATALOGSC-BS-780
CATALOG NUMBERSC-BS-780
MOLECULAR WEIGHTApprox. 146.2 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows blood-brain-barrier penetration, and can be used for Alzheimer's disease (AD) research.
Aducanumab is a recombinant research-use antibody directed against APP.